Looking at the spine in controlled Acromegaly.

Area of Science:

• Endocrinology
• Orthopedics
• Bone Metabolism

Background:

• Growth hormone (GH) hypersecretion in acromegaly is linked to skeletal fragility and vertebral fractures (VFs).
• Vertebral fractures (VFs) frequently co-occur with spine arthropathy, diminishing the quality of life for acromegaly patients.
• Managing spinal osteopathy and arthropathy in acromegaly presents challenges, as these conditions may persist or worsen post-biochemical disease control.

Purpose of the Study:

• To analyze current evidence on the pathophysiological links between VFs and spine arthropathy in acromegaly.
• To review diagnostic strategies for acromegalic osteo-arthropathy.
• To discuss therapeutic approaches for the holistic management of VFs and spine arthropathy in acromegaly.

Main Methods:

• Literature review of recent studies on acromegaly, skeletal fragility, VFs, and spine arthropathy.
• Analysis of pathophysiological mechanisms connecting GH excess to bone and joint complications.
• Evaluation of diagnostic tools and treatment modalities for osteo-arthropathy in acromegaly.

Main Results:

• GH excess contributes to increased skeletal fragility and a higher risk of VFs.
• Spine arthropathy is a common comorbidity with VFs in acromegaly, impacting patient quality of life.
• Effective management requires addressing both VFs and arthropathy, even after achieving biochemical control of acromegaly.

Conclusions:

• Understanding the interplay between VFs and spine arthropathy is crucial for managing acromegaly-related skeletal complications.
• A comprehensive approach integrating diagnosis and treatment is necessary for acromegalic osteo-arthropathy.
• Further research into the long-term management of these conditions post-disease control is warranted.